You are here: Industry Insights > Inhibitors

News List

Made-in-China New Drugs: The Game and Breakthrough in the Over - 4 - Billion Market Lezhi
September 05, 2025
Profiles 16 China-made blockbuster drugs exceeding ￥1B sales, highlighting intense PD-1 competition, EGFR tech innovation, and bispecific antibody/non-oncology surge.
The Global Alpha-Glucosidase Inhibitor Market: Trends and Prospects David Orchard-Webb
March 18, 2025
Alpha-glucosidase inhibitors are used for type 2 diabetes. This article analyzes their market, including growth, segments, and challenges.
Research Progress on 5-Lipoxygenase and Its Inhibitors Xiaonisha
September 05, 2025
Lipoxygenases are a class of non-heme iron-containing dioxygenases present in tissues and cells of both animals and plants.
Research Progress on Nrf2 Activators Based on Natural Products and Their Derivatives (Part I) Xiaonisha
August 22, 2025
The Keap1-Nrf2-ARE signaling pathway is one of the critical mechanisms for cellular defense against oxidative stress damage.
Advances in Research on New Therapeutic Drugs for Myelodysplastic Syndromes (Part one) Xiaomichong
July 09, 2024
Myelodysplastic syndromes (MDS) are a heterogeneous group of hematologic malignancies characterized by defective normal hematopoiesis leading to a reduction in blood cells, with a risk of transformation into acute myeloid leukemia.
A comprehensive review of the currently marketed ADC drugs: the industry maintains high prosperity WND
November 07, 2023
Antibody-drug conjugates (ADCs) are a class of drugs composed of antibodies targeting tumor antigens and a variable number of small molecule toxins linked through connectors.
Drug Marketing in China and Worldwide (August)(2023) PharmaSources
September 01, 2023
The official website shows that the drugs developed by major companies have been declared for marketing.
Are the Fourth Generation EGFR Inhibitors the Next Wealth Creation Myth? PharmaSources/Yefenghong
April 18, 2022
Junshi Biosciences WJ13404 Has Been Submitted for Clinical Application
Weekly Pharmaceutical News Review of PharmaSources.com (January 4th to 7th) PharmaSources/Caicai
January 17, 2022
The new review this week is from January 4 to 7, covering a total of 18 pieces of information in 4 sections, i.e. review, policy, listing, and others.
Global Diabetes Market Outlook Dr. Preet Pal S.B.
November 22, 2021
Diabetes is a well-known metabolic disorder, and the number of people living with it continues to rise. Although it is a segment of opportunity for pharmaceutical manufacturers, understanding it is complex.